Biostatistics in Clinical Trials

Front Cover
Carol K. Redmond, Theodore Colton
John Wiley & Sons, May 2, 2001 - Medical - 522 pages
0 Reviews
The second volume in the Wiley reference series in Biostatistics.
Featuring articles from the prestigious Encyclopedia of Biostatistics, many of which have been fully revised and updated to include recent developments, Biostatistics in Clinical Trials also includes up to 25% newly commissioned material reflecting the latest thinking in:
  • Bayesian methods
  • Benefit/risk assessment
  • Cost-effectiveness
  • Ethics
  • Fraud

With exceptional contributions from leading experts in academia, government and industry, Biostatistics in Clinical Trials has been designed to complement existing texts by providing extensive, up-to-date coverage and introducing the reader to the research literature.
Offering comprehensive coverage of all aspects of clinical trials Biostatistics in Clinical Trials:

  • Includes concise definitions and introductions to numerous concepts found in current literature
  • Discusses the software and textbooks available
  • Uses extensive cross-references helping to facilitate further research and enabling the reader to locate definitions and related concepts

Biostatistics in Clinical Trials offers both academics and practitioners from various disciplines and settings, such as universities, the pharmaceutical industry and clinical research organisations, up-to-date information as well as references to assist professionals involved in the design and conduct of clinical trials.

 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Adaptive and Dynamic Methods
1
Audit and Quality Control
9
BenefitRisk Assessment
18
Blinding or Masking
25
Clinical Significance Versus Statistical
35
Cluster Randomization
51
Cochrane Collaboration
65
Compliance Assessment
76
Missing Data
283
Multiple Endpoints
292
Noncompliance Adjustment
303
NSABP and Advances in
310
Number Needed to Treat NNT
321
Pharmaceutical Industry Statistics
331
Trials
337
Physicians Health Study
348

Cooperative Studies Program
99
Costeffectiveness
115
Covariate Imbalance Adjustment
122
Data and Safety Monitoring
145
Data and Safety Monitoring Boards
154
Drug Approval and Regulation
160
Drug Interactions
172
Equivalence Trials
179
European Federation of Statisticians
189
Grouprandomization Designs
209
Historical Controls Bias From
225
History Overview
235
IntentiontoTreat Analysis
245
Medical Ethics and Statistics
257
Medical Research Council MRC
271
Preclinical Treatment Evaluation
361
Prevention Trials
367
QUOROM
379
Salk Vaccine
393
Screening Trials
406
Sequential Methods
414
Society for Clinical Trials
422
Textbooks
451
Timevarying Treatment Effect
460
University Group Diabetes Program
469
Vaccine Studies
479
225
495
443
500
Copyright

Other editions - View all

Common terms and phrases

References to this book

Bibliographic information